Pulmonx Corporation
LUNG
$1.33
-$0.05-3.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -8.66% | -4.91% | 5.47% | 14.80% | 19.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.66% | -4.91% | 5.47% | 14.80% | 19.54% |
| Cost of Revenue | -26.69% | -18.11% | 1.66% | 21.53% | 29.73% |
| Gross Profit | -1.82% | -0.28% | 6.83% | 12.39% | 16.08% |
| SG&A Expenses | -7.83% | -15.35% | 0.74% | 5.48% | 7.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.59% | -12.59% | 4.00% | 6.20% | 11.11% |
| Operating Income | 11.03% | 26.19% | -1.87% | 5.24% | -0.19% |
| Income Before Tax | 5.65% | 22.06% | 0.88% | 1.61% | -5.53% |
| Income Tax Expenses | 10.37% | 389.47% | -33.33% | 110.71% | -27.42% |
| Earnings from Continuing Operations | 5.50% | 20.87% | 1.32% | 1.00% | -5.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.50% | 20.87% | 1.32% | 1.00% | -5.08% |
| EBIT | 11.03% | 26.19% | -1.87% | 5.24% | -0.19% |
| EBITDA | 10.14% | 26.50% | -2.84% | 4.08% | -0.51% |
| EPS Basic | 9.87% | 24.36% | 5.33% | 4.63% | -1.60% |
| Normalized Basic EPS | 10.00% | 25.46% | 4.91% | 5.23% | -2.05% |
| EPS Diluted | 9.87% | 24.36% | 5.33% | 4.63% | -1.60% |
| Normalized Diluted EPS | 10.00% | 25.46% | 4.91% | 5.23% | -2.05% |
| Average Basic Shares Outstanding | 4.86% | 4.60% | 4.23% | 3.82% | 3.41% |
| Average Diluted Shares Outstanding | 4.86% | 4.60% | 4.23% | 3.82% | 3.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |